Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Ilixadencel by Mendus for Gastrointestinal Stromal Tumor (GIST): Likelihood of Approval
Ilixadencel is under clinical development by Mendus and currently in Phase II for Gastrointestinal Stromal Tumor (GIST). According to GlobalData,...
Data Insights
Ilixadencel by Mendus for Hepatocellular Carcinoma: Likelihood of Approval
Ilixadencel is under clinical development by Mendus and currently in Phase II for Hepatocellular Carcinoma. According to GlobalData, Phase II...